| Product Code: ETC13129742 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Non-Hodgkin Lymphoma Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 North America Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.8 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.9 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.11 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.12 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.12 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 North America Non-Hodgkin Lymphoma Diagnostics Market, 2021 - 2031 |
6.1 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.1.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.1.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Immunohistochemistry, 2021 - 2031 |
6.1.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Biomarker Test, 2021 - 2031 |
6.1.6 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Genetic Test, 2021 - 2031 |
6.1.7 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cytogenetics, 2021 - 2031 |
6.1.8 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Lumbar Puncture (Spinal Tap), 2021 - 2031 |
6.1.9 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage 0, 2021 - 2031 |
6.2.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage I, 2021 - 2031 |
6.2.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage Ii, 2021 - 2031 |
6.2.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage Iii, 2021 - 2031 |
6.2.6 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage Iv, 2021 - 2031 |
6.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Aggressive Lymphomas, 2021 - 2031 |
6.3.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Indolent Lymphomas, 2021 - 2031 |
6.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Instrument Based Products, 2021 - 2031 |
6.4.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Platform Based Products, 2021 - 2031 |
6.4.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Kits And Reagents, 2021 - 2031 |
6.4.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Other Consumables, 2021 - 2031 |
6.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Fluorescent In Situ Hybridization, 2021 - 2031 |
6.5.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Next Generation Sequencing, 2021 - 2031 |
6.5.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Fluorimmunoassay, 2021 - 2031 |
6.5.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Comparative Genomic Hybridization, 2021 - 2031 |
6.5.6 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Immunohistochemical, 2021 - 2031 |
6.5.7 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Screening, 2021 - 2031 |
6.6.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Diagnostic And Predictive, 2021 - 2031 |
6.6.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Prognostic, 2021 - 2031 |
6.6.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Research, 2021 - 2031 |
6.7 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.7.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.7.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Research Centers, 2021 - 2031 |
6.7.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Academic Institutes, 2021 - 2031 |
6.7.6 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.7.7 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.8 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.8.3 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
6.8.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Non-Hodgkin Lymphoma Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
7.3.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.3.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.3.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.4 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.5 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.6 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.7 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.8 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.9 North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.1 United States (US) Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.2 Canada Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.3 Rest of North America Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
9 North America Non-Hodgkin Lymphoma Diagnostics Market - Export/Import By Countries Assessment |
10 North America Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
10.1 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
10.4 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
10.5 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10.6 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.7 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.8 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10.9 North America Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
11.1 North America Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here